IL-13 drugs for Atopic Dermatitis
4 tracked IL-13 drugs in the Atopic Dermatitis race. The class explanation lives on the IL-13 page; the full indication pipeline across every mechanism is on the Atopic Dermatitis page.
2 approved / phase 41 Phase 21 Phase 1
Head-to-head evidence: lebrikizumab vs REGN20423 · REGN20423 vs tralokinumab · lebrikizumab vs Zumilokibart · tralokinumab vs Zumilokibart · lebrikizumab vs tralokinumab